Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
san francisco blog main
6
×
boston blog main
boston top stories
clinical trials
national top stories
new york blog main
san francisco top stories
national
new york top stories
biotech
fda
spark therapeutics
alnylam pharmaceuticals
autoimmune diseases
biotech ipos
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
europe blog main
europe top stories
gene therapy
immunotherapy
indiana blog main
indiana top stories
investing
medicare
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco
seattle blog main
seattle top stories
texas blog main
texas top stories
What
market
6
×
drug
data
fda
gene
medicine
new
patients
payers
science
sets
therapy
advantages
ago
approved
aren’t
arrival
bar
battle
bio
biotech
brings
cancer
cannabis
car
close
companies
cutting
days
derivative
edge
eisai
epilepsy
expect
experiments
flags
form
forward
gamble
gw
Language
unset
Current search:
market
×
" san francisco blog main "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”